Alere Inc. (NYSE:ALR) was upgraded by research analysts at BidaskClub from a “sell” rating to a “hold” rating in a research note issued to investors on Thursday.

Other equities analysts have also issued reports about the company. Zacks Investment Research upgraded Alere from a “sell” rating to a “hold” rating in a research report on Tuesday, June 27th. BTIG Research reiterated a “hold” rating on shares of Alere in a research report on Wednesday, May 24th. Canaccord Genuity lowered Alere from a “buy” rating to a “hold” rating and set a $51.00 price objective on the stock. in a research report on Tuesday, June 6th. Jefferies Group LLC reiterated a “hold” rating and set a $51.00 price objective on shares of Alere in a research report on Thursday, June 1st. Finally, Craig Hallum lowered Alere from a “buy” rating to a “hold” rating in a research report on Monday, May 15th. One equities research analyst has rated the stock with a sell rating and six have assigned a hold rating to the stock. The stock has an average rating of “Hold” and an average price target of $48.00.

Shares of Alere (ALR) traded up 0.45% on Thursday, hitting $49.55. The company had a trading volume of 862,573 shares. The company has a 50 day moving average price of $50.09 and a 200 day moving average price of $45.76. The firm’s market capitalization is $4.34 billion. Alere has a 1-year low of $34.41 and a 1-year high of $50.63.

TRADEMARK VIOLATION WARNING: This piece of content was originally reported by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international copyright & trademark law. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/08/20/alere-inc-alr-upgraded-to-hold-by-bidaskclub.html.

Several large investors have recently modified their holdings of the company. The Manufacturers Life Insurance Company raised its stake in shares of Alere by 7.4% in the second quarter. The Manufacturers Life Insurance Company now owns 2,585 shares of the medical research company’s stock worth $130,000 after buying an additional 179 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Alere by 11.6% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,094 shares of the medical research company’s stock worth $155,000 after buying an additional 321 shares in the last quarter. Jane Street Group LLC raised its stake in shares of Alere by 104.6% in the first quarter. Jane Street Group LLC now owns 5,090 shares of the medical research company’s stock worth $202,000 after buying an additional 115,090 shares in the last quarter. Engineers Gate Manager LP acquired a new stake in shares of Alere during the first quarter worth $265,000. Finally, Prudential Financial Inc. raised its stake in shares of Alere by 5.8% in the second quarter. Prudential Financial Inc. now owns 5,515 shares of the medical research company’s stock worth $277,000 after buying an additional 300 shares in the last quarter. Hedge funds and other institutional investors own 80.53% of the company’s stock.

About Alere

Alere Inc is a provider of health information through diagnostic tests. The Company’s segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus.

Analyst Recommendations for Alere (NYSE:ALR)

Receive News & Ratings for Alere Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alere Inc. and related companies with MarketBeat.com's FREE daily email newsletter.